Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Watertown, MA
SEC filing record 1 source field available
Fiscal year end
30 September
ENANTA PHARMACEUTICALS INC has filed 832 SEC EDGAR filings since 21 Jun 2002

SEC filing history

Showing 376-400 of 831 matching filings.

Per page
25
Current page
16
4

PRIMARY DOCUMENT

Filing date
06 Aug 2020
Reporting date
05 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
01 Jul 2020
Reporting date
29 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
01 Jul 2020
Reporting date
29 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

8-K NEW DIRECTOR - MARK FOLETTA

Filing date
30 Jun 2020
Reporting date
29 Jun 2020
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 May 2020
Reporting date
05 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

8-K Q2 2020 EARNINGS RELEASE

Filing date
06 May 2020
Reporting date
06 May 2020
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Mar 2020
Reporting date
12 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87373

SC 13D/A

Filing date
04 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

8-K 2020 PROXY VOTE

Filing date
02 Mar 2020
Reporting date
26 Feb 2020
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Feb 2020
Reporting date
26 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Feb 2020
Reporting date
26 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Feb 2020
Reporting date
26 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Feb 2020
Reporting date
26 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Feb 2020
Reporting date
26 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Feb 2020
Reporting date
12 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Feb 2020
Reporting date
12 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Feb 2020
Reporting date
12 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Feb 2020
Reporting date
12 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Feb 2020
Reporting date
12 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87373

SC 13G/A filing

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87373

AMENDMENT NO. 2

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87373

SC 13G/A

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87373

SCHEDULE 13G/A

Filing date
12 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .